Today marks a historic milestone in public health.
RTS,S malaria vaccine is finally introduced after 30+ years of development.
Cameroon is the first in Africa to roll out this vaccine.
I encourage @_AfricanUnion Member States to join Cameroon in rolling out this vaccine.
In 2019, @WHO supported the deployment of malaria vaccines in #Ghana🇬🇭, #Kenya🇰🇪 and #Malawi🇲🇼, as part of the pilot phase. 4 years later, the results are very encouraging.
#VaccinesWork#DeafeatMalariaWithVax
Watch👇🏿
https://t.co/kubRhHvnrq
Today marks a historic milestone in public health.
RTS,S malaria vaccine is finally introduced after 30+ years of development.
Cameroon is the first in Africa to roll out this vaccine.
I encourage @_AfricanUnion Member States to join Cameroon in rolling out this vaccine.
Breaking: @WHO certifies Cabo Verde🇨🇻 as malaria-free, joining 43 countries and 1 territory that have received this certification.
Cabo Verde is the third African country to eliminate malaria after Mauritius and Algeria.
More 👉🏿 https://t.co/h77OXpmuWg
Breaking: @WHO certifies Cabo Verde🇨🇻 as malaria-free, joining 43 countries and 1 territory that have received this certification.
Cabo Verde is the third African country to eliminate malaria after Mauritius and Algeria.
More 👉🏿 https://t.co/h77OXpmuWg
📢We are thrilled to announce the #UGHE’s Masters in Global Nursing Leadership Program! The applications for the inaugural cohort are now open to qualified applicants across Africa.
➡️ Learn More about MGNL program: https://t.co/RcBZ0Os7vg
➡️ APPLY HERE: https://t.co/I4dyc6l06q
Check out incredible scenes highlighting today’s inauguration of University Innovation Pod #UniPod; a groundbreaking initiative to foster #innovation and creativity among aspiring entrepreneurs and changemakers.
Check out incredible scenes highlighting today’s inauguration of University Innovation Pod #UniPod; a groundbreaking initiative to foster #innovation and creativity among aspiring entrepreneurs and changemakers.
Our pioneer participants in the CARES (Cabotegravir and Rilpivirine Efficacy and Safety) study have completed 2 years & are exiting the trial. The study offered people living with HIV an injectable medication administered 6 times a year, offering an alternative to daily pills.
@cam_crid Malaria is a major public health problem on the continent and intervention to reduce or eradicate its must come from us. Thank @Dr.charles wondji # intiative
That is the only way to Reliable affordable and accessible Vaccine to our people.
Congratulations @African CDC for prioritizing continent health security.
#PAVM shared insights on the initiatives on-going to achieve the PAVM Bold Goal: “Manufacturing 60% of vaccines needs on the continent” and how can the CSOs join the efforts to advocate w/ MS for friendly policies to enable a strong and sustainable #AfricanVaccineManufacturing.
The key ingredient to becoming a successful researcher is being Inspired by failure and not being defeated by them.
For failures inspired winner and failures defeat losers.
With WHO Response to HIV/AID and @GHSSs goals of ending AIDS , other viral hepatitis B and C and sexual transmitted infections by 2030.
Deep down at Tropical africa communities are faced by new trend of HIV case on dialy bases.